Medicure Inc (TSXV:MPH)(OTC:MCUJF), a pharmaceutical company, announced yesterday its financial results for the quarter ended 30 June 2019.
The company reported adjusted EBITDA for the quarter ended 30 June 2019 at USD103,000 compared to adjusted EBITDA of USD882,000 for the quarter ended 30 June 2018.
The firm posted net loss for the quarter ended 30 June 2019 at USD957,000 compared to net income of USD1.6m for the quarter ended 30 June 2018.
Net loss for the six months ended 30 June 2019 was USD3.7m or USD0.24 per share. This compares to net income of USD3.0m or USD0.19 per share for the six months ended 30 June 2018.
Hansoh Pharmaceutical Group Company collaborates with Atomwise
AbbVie's board declares USD1.07 quarterly cash dividend
Bayer Foundation announces Social Innovation ecosystem fund for African smallholder farmers
Vireo Health International reports Q2 2019 financial results
Veloxis Pharmaceuticals reports on increase in share capital
Concord Medical incurs higher net loss of CNY140.1m for first six months in 2019
Titan Pharmaceuticals announces Q2 2019 financial results
Medicure reports quarter ended 30 June 2019 financial results
Endo International announces Q2 2019 financial results
Deciphera Pharmaceuticals' net loss narrows to USD21.5m in Q2 2019
CONMED Corporation to pay quarterly dividend of USD0.20 per share
Acerus and Aytu Bioscience to Co-promote Natesto in the United States